Tumor Lysis Syndrome @NEJM 2025
Incidence 5-70%, highest in acute leukemias & lymphomas.
Now increasingly associated with targeted therapies & ICIs, even in solid tumors. ICIs >150 cases, 44% mortality
Stratify risk, prophylaxis & act fast
https://t.co/BZRQd7Ly9S @OncoAlert